Below is a report that DML News gives a 3 OUT OF 4 STARS trustworthiness rating. We base this rating on the following criteria:

  • Provides named sources
  • Reported by more than one notable outlet
  • Does not insert opinion or leading words
  • Includes supporting video, direct statements, or photos

Click here to read more about our rating system.

As the most reliable and balanced news aggregation service on the internet, DML News offers the following information published by TheHill.com:

Sen. Cory Booker (D-N.J.) is trying to overcome doubts that he is too close to the pharmaceutical industry ahead of an expected presidential campaign.

The progressive criticism of Booker reached a crescendo in early 2017 when he voted against a budget amendment calling for importing drugs from abroad.

The article goes on to state the following:

The line of attack played into broader fears from progressives that Booker is not tough enough on corporations in general, including Wall Street.

But on Thursday, Booker attempted to show he is tough on drug companies, appearing alongside socialist Sen. Bernie Sanders (I-Vt.), a potential presidential rival, at a press conference on lowering drug prices.

Booker spoke out in strong terms against drug companies and the “outrageous and unjustifiably high cost of prescription drugs.”

To get more information about this article, please visit TheHill.com. To weigh in, leave a comment below.